Trial no.:
|
PACTR201706002163811 |
Date of Approval:
|
31/03/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Comparitive study of Argon Laser and Aspirin in treatment of central serous chorioretinopathy |
Official scientific title |
Comparitive study of Argon Laser and Aspirin in treatment of central serous chorioretinopathy |
Brief summary describing the background
and objectives of the trial
|
Group A: treated with acetylsalicylic acid 150 mg per day orally for 6 months .
Group B: treated with Argon Laser in grid treatment once
Group C: treated with Argon Laser in grid treatment once followed by acetylsalicylic acid 150 mg per day orally for 6 months. Follow up clinically by evaluation of visual acuity and anatomically by OCT every month for six months was done.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
no |
Disease(s) or condition(s) being studied |
defective vision,Eye Diseases,Genetic Diseases,Injury, Occupational Diseases, Poisoning,Mental and Behavioural Disorders |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
07/01/2014 |
Actual trial start date |
17/02/2016 |
Anticipated date of last follow up |
12/10/2016 |
Actual Last follow-up date |
12/10/2016 |
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
60 |
Recruitment status |
Stopped early/ terminated |
Publication URL |
|
|